Space stocks are catching a strong updraft in midday trading. Virgin Galactic (NYSE:SPCE) stock is up 14% to $4.87, while Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) stock is climbing 6% to around $122.
The likely backdrop: SpaceX’s IPO roadshow is currently underway, and the buzz appears to be lifting sentiment across the publicly traded space proxies. Per Financial Times reporting, SpaceX’s IPO could raise up to $86 billion at a pitched valuation of $1.78 trillion, with Goldman Sachs as the lead investment bank.
This looks like a classic IPO halo trade, where heightened attention on a private giant lifts adjacent public names. That framing is plausible, not confirmed, and today’s moves also include a healthy dose of rebound action from recent weakness in both Virgin Galactic stock and Rocket Lab stock.
SpaceX Roadshow Buzz Appears to Lift Public Space Proxies
The SpaceX listing is one of the most anticipated IPOs in years. The prediction markets agree: Polymarket pricing implies a 98.4% probability of a SpaceX IPO by June 30, with the December 31 deadline trading near 99.4%.
SpaceX’s Form S-1 underscores the scale of the franchise drawing in capital. The company says it has raised over $9 billion of equity capital since 2002, and in 2025 its Connectivity segment generated income from operations of $4,423 million and Segment Adjusted EBITDA of $7,168 million. That kind of profile is bringing fresh eyes to anything labeled “space” on a public exchange.
Virgin Galactic and Rocket Lab are two of the most accessible ways for retail traders to get sector exposure today. Reddit chatter reflects it: an investing-subreddit thread asking “How do you think the SpaceX IPO will affect other space stocks (RKLB, ASTS, LUNR, etc.)?” has been a primary driver of RKLB conversation this week.
Rebound Dynamics Are Doing Some of the Work
Today’s pop looks like it’s part of a continuation move. Virgin Galactic stock has been wildly volatile, yet it’s still up 93% over the past month. The fundamentals remain pre-commercial, with Q1 2026 revenue of just $227,000 and a quarterly net loss of $65 million.
However, the longer arc is brutal. Virgin Galactic stock is down 99% over five years, a reminder that IPO-halo enthusiasm and underlying business economics can sit in very different places. CEO Michael Colglazier has stated that the company remains on track to commence flight testing in Q3 and spaceflight in Q4 of this year.
Rocket Lab tells a very different story under the hood. RKLB stock has been volatile heading into today, so the move is partly recovery, yet shares remain up 350% over the past year and 74% year to date.
On the business side, Rocket Lab posted Q1 2026 revenue of $200 million, up 64% year over year, with a backlog of $2.2 billion. CEO Peter Beck declared the quarter “another exceptional quarter with record financial performance of more than $200 million in revenue”, with the Neutron medium-lift rocket on track for a debut launch later in 2026.
What to Watch Into the Close
The near-term catalyst calendar is dense. SpaceX’s roadshow feedback, potential pricing as early as June 11, and a possible June 12 debut under ticker SPCX could keep space-trade sentiment elevated, or trigger profit-taking once the listing prints.
Investors can watch whether today’s gains in Virgin Galactic stock and Rocket Lab stock hold into the close, or fade as a typical volatile-name bounce. Both remain speculative tickers, and prudent investors may want to size their positions accordingly and manage their risk around the SpaceX pricing window.
Beyond the IPO, the next concrete catalysts can come from Rocket Lab’s Neutron debut and Virgin Galactic’s Q3 2026 flight-testing milestone. Those are the moments when IPO-halo enthusiasm could meet, or part ways with, the fundamentals.